Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Displaying 942 questions Show Answers
To ask the Scottish Government what it is doing to support Ukrainian nationals already studying or who wish to study at college or university in Scotland.
To ask the Scottish Government whether it will provide an update on the further implementation of No One Left Behind and how transforming employment support may help to tackle poverty.
To ask the First Minister what action the Scottish Government is taking to reduce the waste of unsold, durable goods in Scotland, in line with the net zero targets.
To ask the Scottish Government what support it is providing to Ukrainian communities in Scotland.
To ask the Scottish Government what progress it has made on identifying support and aid that it can provide for people in Ukraine and Ukrainians leaving their country and seeking refuge.
To ask the Scottish Government how it plans to review and assess the pilots conducted as part of the strategy, The best start: five-year plan for maternity and neonatal care.
To ask the Scottish Government how measures in the Coronavirus (Recovery and Reform) (Scotland) Bill will support the Covid Recovery Strategy.
To ask the Scottish Government, what support is available for wraparound child care services that have been impacted by the COVID-19 pandemic, but remain essential to its new wraparound plans.
To ask the Scottish Government what action it will take in response to the British Academy of Audiology report on NHS Lothian's Paediatric Audiology Services, which was requested by NHS Lothian following a review by the Scottish Public Services Ombudsman.
To ask the Scottish Government whether the emergence of the Omicron variant has influenced its discussions with the UK Government regarding the four-nation approach to vaccine procurement, particularly in relation to the Valneva vaccine and any potential need to deploy different vaccine formulations both domestically and internationally.